JPMORGAN CHASE & CO - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 42 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,409
+9.2%
4960.0%0.00%
Q2 2023$1,290
+29.0%
4960.0%0.00%
Q1 2023$1,000
+99900.0%
4960.0%0.00%
Q4 2022$1
-100.0%
496
-75.6%
0.00%
Q3 2022$4,0000.0%2,032
+43.3%
0.00%
Q2 2022$4,000
-91.8%
1,418
-89.0%
0.00%
Q1 2022$49,000
-31.0%
12,937
+104.7%
0.00%
Q4 2021$71,000
-7.8%
6,321
+43.1%
0.00%
Q3 2021$77,0004,4180.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,474,572$9,329,0007.10%
Novo Holdings A/S 4,840,413$18,248,0000.96%
RA Capital Management 3,350,506$12,631,0000.28%
Avidity Partners Management LP 1,850,000$6,975,0000.14%
ACT CAPITAL MANAGEMENT, LLC 15,000$57,0000.06%
Baker Brothers Advisors 812,640$3,064,0000.02%
CAAS CAPITAL MANAGEMENT LP 105,091$396,0000.02%
Evercore Wealth Management, LLC 146,676$553,0000.01%
Jump Financial, LLC 21,300$80,0000.00%
JANUS HENDERSON GROUP PLC 1,719,610$6,486,0000.00%
View complete list of CYTEIR THERAPEUTICS INC shareholders